Allulose vs Sugar
How allulose compares with table sugar on the things that change a choice: how sweet it is, what it adds in calories, what it does to blood glucose, how it behaves in a recipe and where regulators stand. This page has no figures of its own. Everything below is read from our two sourced records, so when a record is corrected this page changes with it.
At a Glance
Every row below comes from our two sourced records, the same ones the cards at the foot of this page show. Each figure links to the document it came from and the date we last checked it; open “Note” for the qualifications that go with it. Where a record has nothing sourced for a row, the cell says so rather than filling the gap.
| Attribute | Allulose | Sugar (sucrose) |
|---|---|---|
| Sweetness | 70% of sugarXie X, Yu L, Lin Q, Huang D; Journal… peer reviewed checked 30 Aug 2026NoteCommonly cited as approximately 70% of sucrose. Convergent across Xie 2024, Han 2018 and the comments FDA received on the 2014 proposed rule — but this is a repeated figure, not a specification band or a sensory measurement, and no concentration dependence has been characterised the way it has for erythritol. | 100% of sugarCornell Legal Information Institute (eCFR text) regulatory checked 30 Aug 2026NoteBy definition. Sucrose IS the reference against which every other figure in this file is expressed. |
| Calories | 0.4 kcal per gramUS FDA, Center for Food Safety and Applied Nutrition regulatory checked 30 Aug 2026NoteENFORCEMENT DISCRETION, not a rule. FDA states that under 21 CFR 101.9(c)(1)(B) "a caloric value of 4 kcal/g must currently be used for allulose because it is a carbohydrate", and that it merely intends not to enforce that pending rulemaking. Two citizen petitions asked for 0.4 and 0.2; FDA chose the higher figure because it "would not underestimate the caloric contribution". | 4 kcal per gramCornell Legal Information Institute (eCFR text) regulatory checked 30 Aug 2026NoteThe general factor for total carbohydrate under 21 CFR 101.9(c)(1)(i)(B). This is the number every "reduced calorie" claim on this site is implicitly measured against. |
| Net carbs | Subtracts in full — none of its grams countUS FDA, Center for Food Safety and Applied Nutrition regulatory checked 30 Aug 2026NoteFDA: allulose "is virtually unmetabolized in the human body", produces "only a negligible increase in glycemic and insulinemic responses", and provides no more than 0.4 kcal/g. | Counts in full — all of its grams countCornell Legal Information Institute (eCFR text) regulatory checked 30 Aug 2026NoteCounts in full. This is the 1.0 end of the counted-fraction scale. |
| Blood glucose | Negligible; no established GI value — reduces POSTPRANDIAL glucose and insulin (moderate certainty), but no significant effect on HbA1c, fasting glucose/insulin, lipids, uric acid or body compositionOsborn L, DuPuis K, Liu S, Della Corte D,… peer reviewed checked 31 Aug 2026NoteUPDATED 2026-08-31 with the field's current best synthesis, previously flagged in this backlog as bot-blocked — it is Open Access and loads cleanly in a real browser; only automated fetchers (WebFetch, server curl) were gated, the same JS bot-check pattern already on file for EUR-Lex and the ADA Standards of Care. Osborn, DuPuis, Liu, Della Corte & Della Corte 2026 (AJCN 123(6):101314) is a PROSPERO-registered (CRD42024567433) systematic review and meta-analysis of 20 controlled human intervention trials (12 allulose, 8 tagatose; 1,033 participants total), searched through 30 April 2025 — broader than either single study previously cited here. ALLULOSE ARM: significantly reduced postprandial glucose (incremental AUC SMD -0.66, 95% CI -0.92 to -0.39, moderate certainty) and postprandial insulin (SMD -1.27, 95% CI -2.14 to -0.40, moderate certainty) — but NO significant pooled effect on HbA1c, fasting glucose, fasting insulin, blood lipids, uric acid, or body composition (very low to moderate certainty across those outcomes). Read the postprandial finding and the null findings together: the acute glucose/insulin-blunting effect this record has documented since Tani 2023 holds up under a larger, more rigorous synthesis, but it does not extend to weight, fasting markers or long-term glycaemic control on the evidence gathered so far — allulose blunts a spike, it has not been shown to improve the numbers that matter for longer-run metabolic health. No third-party funding; the review's only disclosed conflict (SL) is unrelated consulting/editorial work with no rare-sugar-industry tie, a materially cleaner disclosure than tani2023's Kagawa University rare-sugar-group authorship (still flagged on that source below). Tani 2023 (145 participants/group, healthy adults, mechanism-establishing) and Ayesh 2024 (126 people with type 2 diabetes, first T2D-specific signal) remain cited in full below as the specific studies this broader 2026 synthesis draws on and updates, not as duplicated or superseded claims. | 65 (glucose = 100)Livesey G; Nutrition Research Reviews 16(2):163-191 peer reviewed checked 30 Aug 2026NoteGlucose = 100. Sucrose is a glucose-fructose disaccharide, so only about half of it is glucose on hydrolysis — which is why its GI sits below pure glucose rather than at it. |
| Digestive tolerance | 0.4 g/kg in one sitting · 0.9 g/kg per day · severe symptoms at 0.5 g/kgHan Y et al., Nutrients 10(12):2010 peer reviewed checked 30 Aug 2026NoteHan 2018, two non-randomised dose-escalation experiments (n=30 and n=19), Korean adults aged 21-30 with BMI 18.5-23. Severe diarrhoea appeared at 0.5 g/kg single dose. The authors explicitly warn that "considerably more symptoms may appear in individuals who are old, obese, or with certain metabolic and GI diseases" and flag the small sample and a possibly inadequate one-week washout. Not a regulatory ADI — no authority has set one. | No sourced entry |
| Browning | HighXie X, Yu L, Lin Q, Huang D; Journal… peer reviewed checked 30 Aug 2026NoteBrowns MORE than sucrose, not less. In sponge cake, lightness fell and redness/yellowness rose with allulose level, with the browning index rising sharply above 20% sucrose replacement and antioxidant activity nearly tripling at the highest level. Practical consequence: the window between caramelised and burnt is narrower than with sugar. | No sourced entry |
| Bulk contribution | BulkingXie X, Yu L, Lin Q, Huang D; Journal… peer reviewed checked 30 Aug 2026NoteUsed at sugar-like weights, but above 20% sucrose replacement in sponge cake hardness and chewiness rose significantly, and specific volume fell from 3.36 to 2.96 cm3/g at 50% replacement. A 1:1 swap also under-sweetens at ~70% relative sweetness. | No sourced entry |
| Recrystallisation | Low at typical food-product use levels; concentrated syrup crystallises on storageRoquette Freres SA patent checked 31 Aug 2026Declared interest: Roquette is a sweetener and starch-derivative ingredient manufacturer with a direct commercial interest in D-allulose syrup formulations.NoteSOURCED 2026-08-31, previously flagged unsourced. Runs OPPOSITE to erythritol's mechanism, not the same direction weaker: erythritol recrystallises because it is relatively LOW-solubility for a bulk sweetener (see that record's own recrystallisation_risk note); allulose is markedly MORE soluble, which several independent manufacturer/patent sources describe as the reason it is less prone to gritty recrystallisation than erythritol at typical use concentrations in finished products such as caramel and frozen desserts. That is NOT the same claim as "allulose never crystallises" — a Roquette Frères patent's own storage-stability data (Example 2) found allulose SYRUP at 77% dry solids crystallising out during 4 weeks' storage at 4-15°C, which is exactly why a whole patent literature exists on deliberately crystallisable vs. non-crystallisable D-allulose syrup formulations. Read the two together: the CONCENTRATED-SYRUP ingredient form is a genuine crystallisation risk manufacturers actively manage; a FINISHED product at typical (much lower) allulose concentrations is not. DECLARED INTEREST: Roquette Frères is a sweetener/ingredient manufacturer with a commercial stake in allulose syrup formulations — a different company to the Kagawa/Matsutani interest disclosed on cooling_effect above, which is useful independent corroboration on the general solubility-driven mechanism even though both are industry sources. | No sourced entry |
| United States | GRAS by notificationUS FDA, Office of Food Additive Safety regulatory checked 30 Aug 2026NoteMultiple "no questions" letters: GRN 400 (18 June 2012), Matsutani (12 June 2014), GRN 693 (Samyang, closed 28 August 2017), and later notices. FDA is explicit that such a letter "is not an affirmation that D-psicose is GRAS under 21 CFR 170.35". | No sourced entry |
| European Union | Not authorisedEFSA Panel on Nutrition, Novel Foods and Food Allergens,… regulatory checked 30 Aug 2026NoteREAD THE MECHANISM BEFORE REPEATING THIS. EFSA concluded on 6 May 2025 that "the safety of the NF D-allulose cannot be established" — but the reason is that the applicant stopped responding to EFSA after February 2020, leaving gaps on identity, production process, genotoxicity, stability, batch data and human data. This is an abandoned dossier, NOT a finding of harm. Allulose is a novel food under Regulation (EU) 2015/2283 and cannot lawfully be placed on the EU market without authorisation. | No sourced entry |
Going further
- Allulose: the full guide, with the evidence and the open questions behind each row.
- Sugar (sucrose): the full guide, the baseline every other sweetener here is measured against.
- Sweetener conversion calculator: a replacement amount by weight, where our records support one.
- Net-carb calculator: what a label’s sweeteners do to the carbohydrate count.
- All comparisons.
New comparisons and corrections, as they land.
This page is educational information, not medical or dietary advice. Nutrition and regulatory details change over time — verify against the cited primary sources before relying on them for formulation or health decisions.